Bajaj Finance Ltd. makes a corporate announcement

The proposed fundraise appears growth-led rather than a response to a capital shortfall. As of Q1 FY27, Bajaj Finance reported a standalone CAR of 20.90%, including Tier-II capital, and Tier-I capital of 20.01% as at 30 June 2026 ^[1]. These are substantial buffers, so the proposed preferential issue or QIP is best understood as pre-emptive capital to support balance-sheet expansion while preserving capital headroom—not as a remedy for a breach or weak solvency position.

Alignment with the fundraise

• The Board is scheduled to consider raising funds through a preferential issue, QIP, or other permitted methods, subject to regulatory and shareholder approvals; the size, pricing and final instrument have not yet been announced ^[2].
• An equity fundraise would directly strengthen Tier-I capital. However, because the amount and structure are not yet known, its precise impact on post-issue CAR or Tier-I capital cannot be quantified.
• This is consistent with management’s Q1 commentary: it said capital raising would be considered if growth momentum continued to accelerate, while profit growth should ideally run faster than balance-sheet growth to build resilience ^[3].
• The current capital position therefore provides capacity to grow, but management appears to be seeking additional capital before growth consumes too much of that buffer.

Growth requirement

Management’s stated FY27 guidance is 22–24% year-on-year AUM growth ^[4]. The company had already delivered 24% YoY consolidated AUM growth to Rs 546,944 Crores as of 30 June 2026 ^[5]. Management also indicated a targeted balance sheet of approximately Rs 630,000–650,000 Crores and said that sustained acceleration in growth could prompt a capital raise ^[3].

Implication: the fundraise is aligned with maintaining growth capacity at the upper end of the 22–24% AUM target and supporting a balance sheet approaching the Rs 630,000–650,000 Crores range, while protecting the approximately 20% Tier-I and total-capital buffers. The key uncertainty is the eventual issue size and whether the raise is equity-led, which will determine how much additional capital headroom is created.

The 1 October 2026 board meeting is seeking an enabling approval for a potential equity fund raise, not approval of a fully priced tranche. The disclosed routes are a preferential issue, a QIP, or one or more other permitted methods, subject to applicable regulatory/statutory approvals and shareholder approval wherever required. ^[6]

Resolutions disclosed so far

The prior intimation does not specify:

• the fund-raise size;
• the number or type of securities;
• issue pricing or pricing formula;
• identified investors;
• the number of tranches; or
• a definitive execution date.

It also does not separately identify resolutions relating to authorised share capital, delegation of issue powers, or other implementation mechanics. Those may appear in the detailed board outcome or shareholder notice, but are not stated in the meeting intimation. ^[6]

Execution timeline in previous fund-raising filings

The repeatable pattern is therefore same-day execution for pre-arranged private-placement NCD tranches. However, these were allotment-level approvals by the Debenture Allotment Committee, not the kind of broad equity-raising authorization now being considered by the Board.

For the earlier preferential-warrant raise, the filings record that 25% of the consideration was paid at subscription and allotment, but they do not provide the relevant Board approval date or a sufficiently precise tranche-execution date to calculate an approval-to-execution interval. ^[12] The monitoring-agency filing confirms the preferential issue structure but does not close that timing gap. ^[13]

Analyst read: a defensible “typical” lag is zero days for the company’s recent NCD allotments, but there is no reliable numeric precedent for the proposed QIP/preferential equity raise. The equity transaction should therefore be viewed as a two-stage process: Board enablement first, followed by required approvals, final terms and investor execution. The current filing does not support assuming that an equity tranche will be executed immediately after the 1 October board meeting.

Bajaj Finance has raised capital less frequently than several peers, but its raises have been relatively large and more directly equity-oriented. Across FY24–FY26, the company’s documented equity activity was concentrated in one FY24 programme of Rs 10,000 Crores, followed by the delayed receipt of warrant proceeds in FY25. It then relied mainly on debt-market funding in FY26. Despite that lower equity-raising frequency, Bajaj Finance kept Tier-I CRAR around 21%, or more than 10 percentage points above the 10% regulatory benchmark. ^{[14] [15] [16] [17]}

Tier-I capital comparison

The ratios are year-end statutory disclosures, but the reporting basis is not perfectly uniform: Tata explicitly labels its capital-ratio series as standalone, while the other filings use company-level regulatory capital disclosures. The comparison is therefore directional rather than a fully normalized peer ranking.

Bajaj Finance

• FY24: Bajaj approved a Rs 10,000 Crores capital programme: Rs 8,800 Crores through QIP and Rs 1,200 Crores through preferential warrants to Bajaj Finserv. ^[14]
• FY25: The company received the remaining 75% warrant consideration, amounting to Rs 891.64 Crores; the total consideration received from the warrant issue was reported at Rs 1,188.85 Crores. This was completion of the FY24 transaction, not a new equity programme. ^[15]
• FY26: The principal funding activity identified was approximately USD 615 million of fully hedged ECBs, which supports liquidity and asset growth but does not directly increase Tier-I capital. ^[29]

Bajaj’s Tier-I CRAR eased from 21.51% in FY24 to 20.67% in FY26, but the buffer remained substantial. The decline reflects capital growing more slowly than risk-weighted assets: Tier-I capital increased from Rs 82,233.86 Crores to Rs 95,751.27 Crores between FY25 and FY26, while risk-weighted assets increased from Rs 389,981.09 Crores to Rs 463,323.41 Crores. ^[16] This is a controlled compression of the buffer, not evidence of regulatory capital stress.

Shriram Finance

Shriram’s capital raising was less frequent but materially larger than Bajaj’s. The company pursued a single strategic preferential issue of Rs 39,617.98 Crores to MUFG Bank, representing 20% of post-issue equity; the proceeds were intended for onward lending, repayment of borrowings and general corporate purposes. ^[30] The company separately announced committee meetings to consider private-placement NCDs, but the cited filing did not specify a final amount or confirm an allotment. ^[31]

The MUFG transaction is approximately four times the size of Bajaj’s FY24 Rs 10,000 Crores programme, but Shriram’s FY26 Tier-I CRAR was 19.80%, slightly below its FY25 20.03%. ^[19] The issue therefore created a very large capital base and strategic funding capacity, but the reported year-end ratio was still around the same broad range as Bajaj’s rather than dramatically higher.

Cholamandalam Investment & Finance

Chola shows the highest recurring use of subordinated and Tier-II capital among the cited peers, rather than repeated equity raising:

• FY25: Rs 4,760 Crores of subordinated debt and Rs 1,000 Crores of perpetual debt were reported as amounts raised during the year.
• FY26: the corresponding figures were Rs 2,502 Crores and Rs 100 Crores. ^[32]
• A specific FY26 private-placement allotment involved Rs 500 Crores of unsecured subordinated securities, within a Rs 1,000 Crores issue size including green shoe. ^{[33] [34]}

These instruments support Tier-II, not Tier-I, capital. That distinction explains why Chola’s Tier-I CRAR was only 14.73% in FY26, despite a healthy total CRAR of 19.21%. Its Tier-I buffer of 4.73 percentage points was materially narrower than Bajaj’s 10.67 percentage points. ^[22]

Tata Capital

Tata’s FY26 capital activity was dominated by its listing and IPO. The company described the IPO issue size as Rs 15,512 Crores, larger than Bajaj’s FY24 equity programme. ^[35] The financing cash-flow statement separately reports proceeds from issue of equity shares of Rs 8,583.25 Crores in FY26 versus Rs 1,488.71 Crores in FY25, which is a better indicator of primary equity cash received than the headline IPO size. ^[36]

Tata’s Tier-I CRAR improved from 12.69% in FY25 to 15.85% in FY26. ^[23] The increase is consistent with the equity-raising event strengthening the capital base, but the cited Tata disclosure gives the 15% minimum for total CRAR rather than a separate Tier-I minimum. Its Tier-I surplus should therefore not be presented with the same precision as Bajaj’s or Chola’s.

Muthoot Finance

Muthoot’s documented capital raising was also primarily Tier-II debt, not equity:

• Outstanding subordinated debt qualifying as Tier-II increased from Rs 187.17 Crores in FY25 to Rs 3,000 Crores in FY26. ^[25]
• The FY26 private-placement instrument was a 10-year subordinated debt issue allotted on January 16, 2026. ^[37]

Muthoot’s Tier-I CRAR declined from 22.95% to 19.84% as its risk-weighted assets expanded sharply, but it still retained a wide capital cushion. On a normalized 10% benchmark, the FY26 surplus would be approximately 9.84 percentage points, slightly below Bajaj’s but well above Chola’s.

L&T Finance

L&T Finance raised Rs 1,500 Crores through senior secured NCDs in May 2025. ^[38] Its FY26 annual report also records Rs 250 Crores of subordinated debt raised during the year, but the reported Tier-II amount does not directly increase Tier-I capital. ^[27]

Its Tier-I CRAR fell from 21.02% in FY24 to 17.60% in FY26, though this remained 8.60 percentage points above the company-stated 9% Tier-I minimum. ^{[28] [27]} Relative to Bajaj, L&T Finance therefore used more visible debt-market funding while operating with a progressively thinner, though still comfortable, Tier-I buffer.

Institutional takeaway

• Bajaj: lower-frequency, high-value equity raising; strong and consistently wide Tier-I buffer.
• Shriram: one transformational equity raise, far larger than Bajaj’s, but with FY26 Tier-I CRAR still near 20%.
• Tata: large listing-related equity event, with a clear improvement in Tier-I CRAR, although the exact Tier-I regulatory buffer is not separately stated.
• Chola and Muthoot: more visible subordinated/Tier-II issuance; these raises support total CRAR more directly than Tier-I.
• L&T Finance: regular debt-market access and a still-strong Tier-I ratio, but with greater buffer compression than Bajaj.

The central distinction is therefore not simply how often an NBFC raises funds. Equity raises such as Bajaj’s FY24 programme, Shriram’s MUFG transaction and Tata Capital’s IPO directly reinforce Tier-I capital. Subordinated debt and ordinary NCDs, more prominent at Chola, Muthoot and L&T Finance, primarily support funding capacity or Tier-II capital and should not be treated as equivalent Tier-I capital raises.